Clare Walton
@cawalton.bsky.social
Fast talker, fast eater, slow runner. Former bird neuro researcher. Passionate about science communication, PPI and research for patient benefit. Head of Research at UK MS Society, all views my own
Reposted by Clare Walton
A paper to be proud of from a fab team. ocrelizumab pregnancy registry data, with over 3000 recorded pregnancies, >800 treated within 3 months of pregnancy and >500 of those with outcomes. We need this kind of data to improve shared decision making around pregnancy.
www.neurology.org/doi/10.1212/...
www.neurology.org/doi/10.1212/...
Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab | Neurology Neuroimmunology & Neuroinflammation
Background and ObjectivesOcrelizumab labeling advises contraception for women during treatment and for 6–12
months thereafter. Because pregnancies may occur during this time, it is critical
to underst...
www.neurology.org
December 19, 2024 at 7:46 AM
A paper to be proud of from a fab team. ocrelizumab pregnancy registry data, with over 3000 recorded pregnancies, >800 treated within 3 months of pregnancy and >500 of those with outcomes. We need this kind of data to improve shared decision making around pregnancy.
www.neurology.org/doi/10.1212/...
www.neurology.org/doi/10.1212/...
Oh another new platform, at least this feels nicely familiar...
November 26, 2024 at 12:42 PM
Oh another new platform, at least this feels nicely familiar...